Target the Gene master thesis dedication examples Silence the Disease


Phase 1
Phase 2
Phase 3
  • ARO-AAT (Alpha-1 Liver Disease)
    Alpha-1 Liver Disease
  • ARO-APOC3 (Hypertriglyceridemia)
  • ARO-ANG3 (Dyslipidemia)
  • ARO-ENaC (Cystic Fibrosis)
    Cystic Fibrosis
  • ARO-HIF2 (Renal Cell Carcinoma)
    Renal Cell Carcinoma
  • ARO-HBV (Hepatitis B)
    Hepatitis B
    Partnered with Janssen
  • AMG 890 (Cardiovascular Disease)
    Cardiovascular Disease
    Partnered with Amgen
  • ARO-AMG1 (Cardiovascular Disease)
    Cardiovascular Disease
    Partnered with Amgen
  • Liver
  • Lung
  • Tumor

Science Arrowhead has established a robust and versatile drug discovery and development platform based on proprietary technologies, broad licenses to fundamental intellectual property and extensive scientific expertise after more than a decade working on RNAi-based therapies.

follow link Learn More

About Arrowhead

follow url Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.

source site  

creating an essay Learn More